Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 271 Posts
1 2 3 ... 17
AskSlim Market Week, Aug. 3
Article By: Steve Miller Saturday, August 3, 2019 10:00 AM EDT
A look back at the past market week and a look ahead, with some caveats and opportunities.
In this article: AMD, FLR, HUM, K, CSIQ, AMGN, NTAP, SPWR, SQ, UAA
Read
Political Football Stocks
Article By: Bill Smead Tuesday, July 9, 2019 10:56 PM EDT
It is never fun for a sector to be a political football and get kicked around like the banks have been and the pharma/biotech complex is now.
In this article: MRK, AMGN, SPX Also: BAC, JPM, WFC, MO
Read
Undervalued Growth And Dividend Growth In Health Technology
Article By: Chuck Carnevale Wednesday, March 20, 2019 11:13 AM EDT
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.
In this article: ABBV, AGN, AMGN, BMY, BIIB, CELG, GILD, MYL, PFE, PRGO
Read
E Daily Stock Tip: Amgen Inc
Article By: Fredrik Arnold Wednesday, February 27, 2019 3:15 AM EDT
I'm looking for another healthcare sector representative for my portfolio. Here's a large-cap big pharma: AMGN.
In this article: AMGN
Read
3 Biotech Stocks With Strong Quantitative Drivers
Article By: Andres Cardenal Wednesday, February 13, 2019 6:18 AM EDT
Investing in biotech stocks can lead to massive gains when positioned in the right names in such a promising industry. However, picking the best biotech stocks is much easier said than done.
In this article: AMGN, BIIB, GILD
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research Wednesday, January 23, 2019 2:06 PM EDT
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
Long Idea Highlights From 2018
Article By: David Trainer Monday, January 21, 2019 12:00 PM EDT
These are the Long Idea highlights from 2018.
In this article: NPK, OCLR, AMGN
Read
Thirteen Companies Boosting Distributions For Long-Term Shareholders
Article By: Dividend Growth Investor Monday, December 17, 2018 1:16 PM EDT
An increase that is well below the rate of dividend growth indicates caution, while an increase that is close to or higher than the average indicates optimism.
In this article: O, BEN, T, AMGN, ERIE, GGG, THG, PFE, ABT, D, UBA, WM, VTR
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Sunday, October 28, 2018 2:00 PM EDT
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
Is Now A Good Time To Buy Amgen?
Article By: Andres Cardenal Monday, September 24, 2018 2:05 PM EDT
Amgen is a high-quality business generating strong cash flows. From a quantitative perspective, the numbers bode well for investors in Amgen going forward.
In this article: AMGN Also: NVO, IBB, BIIB, CELG
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research Sunday, August 12, 2018 4:27 PM EDT
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly Saturday, August 11, 2018 9:37 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
Week In Review: Two Hong Kong IPOs - BeiGene And Ascletis - Raise A Combined $1.3 Billion
Article By: ChinaBio® Today Saturday, August 4, 2018 4:27 PM EDT
BeiGene, a Beijing oncology company, raised $900 million in a debut offering on the Hong Kong stock exchange. Ascletis Pharma of Hangzhou completed a $400 million IPO on the Hong Kong exchange at a $2 billion capitalization
In this article: AMGN, BGNE
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
Biotechs Cruise Onto Green Screen: July Looks Good
Article By: Rod Raynovich Thursday, July 19, 2018 12:16 PM EDT
Biotechs cruised through the choppy market of late June to rally with many mid-caps rolling up and major ETFs up creeping toward 2018 highs. However, with earnings reports coming up, we could expect some selling depending on top line growth.
In this article: FBT, MRK, NVS, ACAD, IBB, CELG, VRTX, XBI, NVCR, CRSP, AMGN, CTNI, JNJ
Read
The Top 11 Big Pharma Dividend Stocks Ranked By Total Return
Article By: SureDividend Monday, July 16, 2018 8:04 PM EDT
Drug companies are often considered defensive in nature due to their stable earnings, through good economies and bad.
In this article: LLY, MRK, AZN, BMY, AMGN, GILD, PFE, ABBV, GSK, NVS, SNY
Read
1 to 16 of 271 Posts
1 2 3 ... 17